Epithelial-to-Mesenchymal Transdifferentiation of Renal Tubular Epithelial Cell Mediated by Oxidative Stress and Intervention Effect of Probucol in Diabetic Nephropathy Rats

REFERENCES

• Soldatos G, Cooper ME. Diabetic nephropathy: Important pathophysiologic mechanisms. Diabetes Res Clin Pract. 2008;82(Suppl. 1):S75–79.
   Google Scholar
• Hills CE, Squires PE. The role of TGF-beta and epithelial-to-mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev. 2011;22:131–139.
   PubMed Web of Science ®Google Scholar
• Hills CE, Al-Rasheed N, Al-Rasheed N, Willars GB, Brunskill NJ. C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: Implications for treatment of diabetic nephropathy. Am J Physiol Renal Physiol. 2009;296:F614–F621.
   PubMed Web of Science ®Google Scholar
• Hills CE, Squires PE. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol. 2010;31:68–74.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liao Q, Luo Y, Qing Z, Zhang Q, He G. Renal protective effect of Rosa laevigata Michx by the inhibition of oxidative stress in streptozotocin-induced diabetic rats. Mol Med Report. 2012;5:1548–1554.
   PubMed Web of Science ®Google Scholar
• Sanchez AP, Sharma K. Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev Mol Med. 2009; 11:e13.
   PubMed Web of Science ®Google Scholar
• Kang MY, Park YH, Kim BS, Seo SY. Preventive effects of green tea (Camellia Sinensis var. Assamica) on diabetic nephropathy. Yonsei Med J. 2012;53:138–144.
   PubMed Web of Science ®Google Scholar
• Du J, Wang L, Liu X, . Janus kinase 2/signal transducers and activators of transcription signal inhibition regulates protective effects of probucol on mesangial cells treated with high glucose. Biol Pharm Bull. 2010;33:768–772.
   PubMed Web of Science ®Google Scholar
• Atsumi H, Kitada M, Kanasaki K, Koya D. Reversal of redox-dependent inhibition of diacylglycerol kinase by antioxidants in mesangial cells exposed to high glucose. Mol Med Report. 2011;4:923–927.
   PubMed Web of Science ®Google Scholar
• Endo K, Miyashita Y, Sasaki H, . Probucol delays progression of diabetic nephropathy. Diabetes Res Clin Pract. 2006;71:156–163.
   PubMed Web of Science ®Google Scholar
• Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol. 2003;14:S250–S253.
   PubMed Web of Science ®Google Scholar
• Tesch GH, Nikolic-Paterson DJ. Recent insights into experimental mouse models of diabetic nephropathy. Nephron. 2006;104:e57–e62.
   Web of Science ®Google Scholar
• Wang H, Li J, Yu L, Zhao Y, Ding W. Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis. Life Sci. 2004;74:1645–1658.
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev. 2008;4:39–45.
   PubMedGoogle Scholar
• Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010;17: 4256–4269.
   PubMed Web of Science ®Google Scholar
• Rhyu DY, Yang Y, Ha H, . Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol. 2005;16: 667–675.
   PubMed Web of Science ®Google Scholar
• Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando). 2008;22:1–5.
   PubMedGoogle Scholar
• Djamali A, Vidyasagar A, Adulla M, Hullett D, Reese S. Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant. 2009;9:74–82.
   PubMed Web of Science ®Google Scholar
• Zhang A, Jia Z, Guo X, Yang T. Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol. 2007;293:F723–F731.
   Google Scholar
• Vayalil PK, Iles KE, Choi J, Yi AK, Postlethwait EM, Liu RM. Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. Am J Physiol Lung Cell Mol Physiol. 2007;293:L1281–L1292.
   PubMed Web of Science ®Google Scholar
• Kang JH, Chae YM, Park KK, Kim CH, Lee IS, Chang YC. Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo. J Cell Biochem. 2008;103:663–674.
   PubMed Web of Science ®Google Scholar
• De Haan JB, Crack PJ, Flentjar N, Iannello RC, Hertzog PJ, Kola I. An imbalance in antioxidant defense affects cellular function: The pathophysiological consequences of a reduction in antioxidant defense in the glutathione peroxidase-1 (gpx1) knockout mouse. Redox Rep. 2003;8: 69–79.
   PubMed Web of Science ®Google Scholar
• Kornhauser C, Garcia-Ramirez JR, Wrobel K, Perez-Luque EL, Garay-Sevilla ME, Wrobel K. Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients. Prim Care Diabetes. 2008;2:81–85.
   PubMedGoogle Scholar
• Lee EA, Seo JY, Jiang Z, . Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Kidney Int. 2005;67:1762–1771.
   PubMed Web of Science ®Google Scholar
• Kondo S, Shimizu M, Urushihara M, . Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat. J Am Soc Nephrol 2006;17:783–794.
   PubMed Web of Science ®Google Scholar
• Li G, Yin L, Liu T, . Role of probucol in preventing contrast-induced acute kidney injury after coronary interventional procedure. Am J Cardiol. 2009;103:512–514.
   PubMed Web of Science ®Google Scholar